Search results
Novavax Stock (NASDAQ:NVAX): Too Much Bad News Can Fuel a Reversal
TipRanks via Yahoo Finance· 3 months agoBy most measures, investors have reason to be skeptical about vaccine specialist Novavax...
Novavax Stock May Soar 379%, According to Wall Street. Is the Stock a Buy Right Now?
Motley Fool via Yahoo Finance· 3 months agoNovavax (NASDAQ: NVAX) soared more than 2,700% early in the pandemic as investors bet on its ability...
Novavax (NVAX) to Receive $350M From Canada, Stock Rises 30%
Zacks via Yahoo Finance· 10 months agoNovavax (NVAX) is set to receive $350M from the Canadian government for forfeited Covid-19 vaccine...
Could This Bullish News Make Novavax a Hot Buy?
Motley Fool· 2 years agoNovavax (NASDAQ: NVAX) is a beaten-down COVID stock that has seen its shares plummet 85% since the start of the year. For people who prefer a more...
Novavax Stock Is Too Sickly To Buy
InvestorPlace via Yahoo Finance· 2 years agoNovavax’s Covid-19 vaccine still isn’t approved for use in the U.S. With the pandemic in full retreat and the majority of people now fully vaccinated,...
Novavax's Vaccine Won U.S. Authorization: 5 Reasons Why Its Stock Still Crashed
Motley Fool· 2 years agoNovavax's (NASDAQ: NVAX) long wait is over. You might think that the good news would have caused Novavax's shares to skyrocket. Here are five reasons why Novavax stock crashed after winning U.S. authorization.
Novavax Dives As Pfizer, Moderna Snag First Nods For Covid Boosters
Investor's Business Daily· 8 months agoNovavax stock crumbled Monday after the Food and Drug Administration signed off on updated Covid...
Novavax Stock: Buy, Sell, or Hold in 2023?
Motley Fool· 1 year agoIn the early days of the pandemic, investors bet Novavax (NASDAQ: NVAX) would be a coronavirus vaccine winner. When the biotech's vaccine candidate fell...
Novavax Stock Soars 25%. A Vaccine Purchase Settlement Is One Reason Why.
Barrons.com· 2 months agoNovavax was rising sharply Thursday after the vaccine maker reached a settlement with...
Will Novavax's Covid Booster Thesis Play Out? What The Survey Says
Investor's Business Daily· 2 years agoNovavax's Covid booster is preemptively gaining steam, according to the July IBD/TIPP Poll. The...
